Stock Scorecard



Stock Summary for Abbvie Inc (ABBV)

Total Score

13 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ABBV

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ABBV

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ABBV

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for ABBV

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Financial Details for ABBV

Company Overview

Company Name Abbvie Inc
Country USA
Description AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2022
Next Earnings Date 1/31/2023

Stock Price History

Last Day Price 159.62
Last Day Volume 1,658,536
Average Daily Volume 5,472,099
52-Week High 171.07
52-Week Low 110.78
Last Price to 52 Week Low 44.09 %

Valuation Measures

Trailing PE 21.25
Industry PE 36.51
Sector PE 93.04
5-Year Average PE 10.18
Free Cash Flow Ratio 23.75
Industry Free Cash Flow Ratio 8.16
Sector Free Cash Flow Ratio 37.55
Book Value Per Share Most Recent Quarter 9.04
Price to Book Ratio 17.14
Industry Price to Book Ratio 5.99
Sector Price to Book Ratio 15.35
Price to Sales Ratio Twelve Trailing Months 4.88
Industry Price to Sales Ratio Twelve Trailing Months 66.86
Sector Price to Sales Ratio Twelve Trailing Months 25.22

Share Statistics

Total Shares Outstanding 1,768,480,000
Market Capitalization 282,284,777,600
Institutional Ownership 0.00 %

Dividends

Ex-Dividend Date 1/12/2023
Last Dividend Amount 1.41
Current Dividend Amount 1.48
Dividend Aristocrat? False
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00 %
Trailing Annual Dividend Rate 5.64
Trailing Annual Dividend Yield 3.70 %
5-Year Average Dividend Yield 0.00 %
5-Year Dividend Payments Count 21
Dividend Payout Ratio 0.00 %

Income Statement

Quarterly Earnings Growth YOY 24.20 %
Annual Earnings Growth 150.04 %
Reported EPS Past Year 10.19
Reported EPS Prior Year 12.70
Net Income Twelve Trailing Months 13,407,000,000
Net Income Past Year 11,542,000,000
Net Income Prior Year 4,616,000,000
Quarterly Revenue Growth YOY 3.30 %
5-Year Revenue Growth 18.80 %

Balance Sheet

Total Cash Per Share 6.72
Total Cash Most Recent Quarter 11,879,000,000
Total Cash Past Year 9,830,000,000
Total Cash Prior Year 8,479,000,000
Net Cash Position Most Recent Quarter -48,520,000,000
Net Cash Position Past Year -66,132,000,000
Long Term Debt Past Year 75,962,000,000
Long Term Debt Prior Year 84,948,000,000
Total Debt Most Recent Quarter 60,399,000,000
Equity to Debt Ratio Past Year 0.17
Equity to Debt Ratio Most Recent Quarter 0.21
Current Ratio Most Recent Quarter 0.93
Total Stockholder Equity Past Year 15,408,000,000
Total Stockholder Equity Prior Year 13,076,000,000
Total Stockholder Equity Most Recent Quarter 15,994,000,000

Options

Put/Call Ratio 0.52
Has Options Options Chain
Liquidity Rating

Technical Analysis

MACD 3.46
MACD Signal 2.66
20-Day Bollinger Lower Band 138.07
20-Day Bollinger Middle Band 144.78
20-Day Bollinger Upper Band 151.50
Beta 0.66
RSI 70.09
50-Day SMA 142.85
200-Day SMA 99.03

System

Modified 11/25/2022 9:20:05 PM